38 results
8-K
EX-99.1
ACST
Acasti Pharma Inc - Ordinary Shares
13 Nov 23
Acasti Announces Second Quarter 2024 Financial Results and Business Highlights
12:00am
on potential NDA submission package.
Exhibit 99.1
Hosted a Key Opinion Leader Event GTX-104: A Potential New Treatment Standard for Rare and Life
8-K
EX-99.1
ACST
Acasti Pharma Inc - Ordinary Shares
5 Jul 23
Other Events
4:00pm
) on the protocol for its pivotal Phase 3 trial of GTX-104 and the FDA also provided guidance for a potential GTX-104 New Drug Application (NDA) package
424B3
ACST
Acasti Pharma Inc - Ordinary Shares
15 Jul 21
Prospectus supplement
4:45pm
to those Acasti common shares. Your bank, brokerage firm or other nominee will send you, as the beneficial shareholder, a package describing
S-4/A
ACST
Acasti Pharma Inc - Ordinary Shares
13 Jul 21
Registration of securities issued in business combination transactions (amended)
4:41pm
or other nominee will send you, as the beneficial shareholder, a package describing the procedure for voting your Acasti common shares. You should follow
S-4
6w1 5as6rla1x53
1 Jul 21
Registration of securities issued in business combination transactions
12:00am
10-Q
ov7kvqfer4zp1x1 3e2v
13 Aug 20
Quarterly report
8:30am
8-K
EX-99.1
7r630mosq kqdsx
13 Aug 20
Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2021
8:30am
8-K
EX-99.1
d3r7f6oc
31 Jul 20
Regulation FD Disclosure
4:05pm
10-K
j76wu51o9s0trp883
29 Jun 20
Annual report
4:02pm
8-K
EX-99.1
zyga k1ever8mv
29 Jun 20
Acasti Pharma Provides Fiscal 2020 Year-End Business Update
12:50pm
8-K
EX-99.1
tl497jdv75h67a50
19 Jun 20
Acasti Pharma Receives FDA Response to TRILOGY 1 Briefing Package
9:09am
8-K
hdmn497aap yq9d
19 Jun 20
Acasti Pharma Receives FDA Response to TRILOGY 1 Briefing Package
9:09am
8-K
4e2j1791a100 8jcd
30 Apr 20
Acasti Pharma Announces Submission of TRILOGY 1 Briefing Package to FDA
4:22pm
8-K
EX-99.1
x85342cg4ryxia26e4
30 Apr 20
Acasti Pharma Announces Submission of TRILOGY 1 Briefing Package to FDA
4:22pm
6-K
EX-99.1
a1bhzx2y4di7jbn
14 Feb 20
Current report (foreign)
8:00am
6-K
EX-99.2
78vmphjtwg1 xgouv
14 Feb 20
Current report (foreign)
8:00am
6-K
EX-99.1
c08b944
14 Feb 20
Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2020
8:00am
6-K
EX-99.1
tq3xi3kawl9s20zqmuq
13 Nov 19
Current report (foreign)
7:55am
6-K
EX-99.2
24go nivz1kbrema
13 Nov 19
Current report (foreign)
7:55am